A detailed history of Greenwood Capital Associates LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 1,917 shares of ABT stock, worth $217,387. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,917
Previous 1,948 1.59%
Holding current value
$217,387
Previous $202,000 7.92%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$100.07 - $118.13 $3,102 - $3,662
-31 Reduced 1.59%
1,917 $218,000
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $209,719 - $234,100
-2,082 Reduced 51.66%
1,948 $202,000
Q1 2024

May 01, 2024

SELL
$109.52 - $120.96 $12,156 - $13,426
-111 Reduced 2.68%
4,030 $458,000
Q4 2023

Mar 05, 2024

SELL
$90.19 - $110.4 $4.9 Million - $6 Million
-54,315 Reduced 92.92%
4,141 $455,000
Q3 2023

Oct 18, 2023

BUY
$95.53 - $114.62 $360,339 - $432,346
3,772 Added 6.9%
58,456 $5.66 Million
Q2 2023

Aug 07, 2023

BUY
$100.78 - $112.29 $5.11 Million - $5.7 Million
50,733 Added 1284.05%
54,684 $5.96 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $382,693 - $450,453
3,951 New
3,951 $400,000
Q1 2019

May 03, 2019

SELL
$66.22 - $80.06 $6.45 Million - $7.8 Million
-97,417 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$65.56 - $74.27 $1.64 Million - $1.86 Million
25,088 Added 34.69%
97,417 $7.05 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $23,898 - $28,830
-393 Reduced 0.54%
72,329 $5.31 Million
Q2 2018

Aug 07, 2018

BUY
$57.57 - $63.54 $1.21 Million - $1.34 Million
21,033 Added 40.69%
72,722 $4.44 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $199,252 - $225,278
3,541 Added 7.35%
51,689 $3.1 Million
Q4 2017

Feb 02, 2018

BUY
$53.68 - $57.47 $2.58 Million - $2.77 Million
48,148
48,148 $2.75 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.